Twist Bioscience

Twist Bioscience Corporation is a synthetic biology company specializing in the manufacture and sale of synthetic DNA-based products. Founded in 2013 and headquartered in South San Francisco, California, the company employs a proprietary silicon-based DNA synthesis platform that allows for high-quality, rapid, and cost-effective production of synthetic DNA. This innovative approach enables the creation of various products, including synthetic genes, antibody libraries for drug discovery, and tools for sample preparation. Twist Bioscience serves diverse sectors such as healthcare, agriculture, and industrial chemicals, supporting customers in their efforts to develop sustainable solutions and improve lives. Additionally, the company has established collaborations, including one with ImmunoPrecise Antibodies Ltd., to enhance its offerings and expand its impact in the field of synthetic biology.

Mark Buck

Senior Vice President Operations

3 past transactions

iGenomX

Acquisition in 2021
iGenomX International Genomics Corporation manufactures High-Throughput Rapid Library Prep (HT-RLP) tool to maximize laboratory capacity and statistical power for population and disease genetics, agricultural, food safety, microbiome, and synthetic biology applications. Its tool offer next-gen genotyping, microbiome genomic analysis, and synthetic biology. The company was incorporated in 2012 and is based in Carlsbad, California.

Sphere Fluidics

Grant in 2017
Sphere Fluidics Limited is a life sciences company focused on developing innovative technologies for single-cell analysis and characterization. The company offers specialized cell analysis systems that facilitate the discovery of new cell strains and molecules, aiding scientists in screening for and isolating rare biological variants. Their products serve various applications, including research, therapeutic development, bioproduction, and diagnostics. By providing collaborative research and development services, Sphere Fluidics aims to help clients enhance efficiency, reduce costs, and accelerate advancements in biological and biopharmaceutical discovery.

Genome Compiler

Acquisition in 2016
Genome Compiler Corporation offers a software platform tailored for genetic engineers and synthetic biologists, facilitating DNA design, visualization, data management, and collaborative efforts. The platform includes tools for designing and debugging biological code, along with repositories for plasmids and parts, and connections to DNA synthesis providers. By integrating lab automation services, Genome Compiler enables users to efficiently create combinatorial designs for their projects. Incorporated in 2011 and based in Los Altos, California, Genome Compiler operates as a subsidiary of Twist Bioscience Corporation. Its solutions support professionals in biotechnology, agriculture, and pharmaceuticals, aiming to streamline the development of innovative, bio-based products.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.